GOVX

$1.6

$

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Next Earnings

2026-02-25

Beta

3.758

Average Volume

Market Cap

Last Dividend

CIK

0000832489

ISIN

US3736787058

CUSIP

373678705

CEO

David Alan Dodd

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

17

IPO Date

2020-09-25

Status

Active

Latest News

Title Headline Publisher Date
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? GeoVax Labs Inc. (NASDAQ: GOVX - Get Free Report) was up 21.1% on Friday. The company traded as high as $0.2105 and last traded at $0.2070. Approximately 6,520,937 shares changed hands during mid-day trading, an increase of 75% from the average daily volume of 3,732,439 shares. The stock had previously closed at $0.1710. Wall Street Defense World 2026-01-03 02:10:53

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-17 2026-02-17 View Filing
8-K 2026-02-17 2026-02-17 View Filing
424B5 2026-02-17 2026-02-17 View Filing
SC 13G/A 2026-02-17 2026-02-17 View Filing
SC 13G/A 2026-02-13 2026-02-13 View Filing
SC 13G 2026-02-11 2026-02-11 View Filing
424B5 2026-01-26 2026-01-26 View Filing
8-K 2026-01-12 2026-01-12 View Filing
8-K 2025-12-22 2025-12-22 View Filing
424B4 2025-12-22 2025-12-22 View Filing
EFFECT 2025-12-19 2025-12-22 View Filing
S-1 2025-12-12 2025-12-12 View Filing
8-K 2025-11-26 2025-11-26 View Filing
8-K 2025-11-13 2025-11-13 View Filing
424B3 2025-11-13 2025-11-13 View Filing
424B3 2025-11-13 2025-11-13 View Filing
424B3 2025-11-13 2025-11-13 View Filing
424B3 2025-11-13 2025-11-13 View Filing
10-Q 2025-11-13 2025-11-13 View Filing
SC 13G/A 2025-11-07 2025-11-07 View Filing
424B3 2025-11-07 2025-11-07 View Filing
S-1 2025-10-17 2025-10-17 View Filing
DEF 14A 2025-10-14 2025-10-14 View Filing
PRE 14A 2025-10-03 2025-10-03 View Filing
8-K 2025-09-30 2025-09-30 View Filing
424B5 2025-09-30 2025-09-30 View Filing
25-NSE 2025-09-29 2025-09-29 View Filing
424B5 2025-09-19 2025-09-19 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
4 2025-08-08 2025-08-08 View Filing
8-K 2025-08-01 2025-08-01 View Filing
8-K 2025-07-29 2025-07-28 View Filing
424B3 2025-07-29 2025-07-28 View Filing
424B3 2025-07-29 2025-07-28 View Filing
424B3 2025-07-29 2025-07-28 View Filing
424B3 2025-07-29 2025-07-28 View Filing
424B3 2025-07-29 2025-07-28 View Filing
10-Q 2025-07-28 2025-07-28 View Filing
SC 13G 2025-07-08 2025-07-08 View Filing
SC 13G 2025-07-07 2025-07-07 View Filing
8-K 2025-07-02 2025-07-02 View Filing
424B4 2025-07-02 2025-07-02 View Filing
EFFECT 2025-07-01 2025-07-01 View Filing
S-1/A 2025-06-26 2025-06-26 View Filing
S-1 2025-06-16 2025-06-16 View Filing
S-8 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
4 2025-06-06 2025-06-06 View Filing
8-K 2025-06-05 2025-06-05 View Filing
SC 13G 2025-05-15 2025-05-15 View Filing
424B3 2025-05-01 2025-05-01 View Filing
424B3 2025-05-01 2025-05-01 View Filing
424B3 2025-05-01 2025-05-01 View Filing
424B3 2025-05-01 2025-05-01 View Filing
424B3 2025-05-01 2025-05-01 View Filing
8-K 2025-05-01 2025-05-01 View Filing
10-Q 2025-05-01 2025-05-01 View Filing
8-K 2025-04-14 2025-04-14 View Filing
DEF 14A 2025-04-14 2025-04-14 View Filing
4 2025-04-11 2025-04-11 View Filing
4 2025-04-10 2025-04-10 View Filing
4 2025-04-01 2025-04-01 View Filing
4 2025-03-31 2025-03-31 View Filing
EFFECT 2025-03-31 2025-03-31 View Filing
EFFECT 2025-03-31 2025-03-31 View Filing
EFFECT 2025-03-31 2025-03-31 View Filing
EFFECT 2025-03-31 2025-03-31 View Filing
EFFECT 2025-03-31 2025-03-31 View Filing
PRE 14A 2025-03-28 2025-03-28 View Filing
8-K 2025-03-28 2025-03-28 View Filing
POS AM 2025-03-27 2025-03-27 View Filing
POS AM 2025-03-27 2025-03-27 View Filing
POS AM 2025-03-27 2025-03-27 View Filing
POS AM 2025-03-27 2025-03-27 View Filing
POS AM 2025-03-27 2025-03-27 View Filing
10-K 2025-03-27 2025-03-27 View Filing
8-K 2025-03-25 2025-03-25 View Filing
424B5 2025-03-25 2025-03-25 View Filing
SC 13G/A 2025-02-14 2025-02-14 View Filing
8-K 2025-01-22 2025-01-22 View Filing
8-K 2024-12-18 2024-12-18 View Filing
8-K 2024-11-18 2024-11-18 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
8-K 2024-11-13 2024-11-13 View Filing
424B3 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
10-Q 2024-11-12 2024-11-12 View Filing
8-K 2024-10-16 2024-10-16 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Parabolic SAR Strategy 12.50% 0.98 39 0.23 0.13 56.96
MACD 10.73% 1.16 14 0.64 0.7 55.2
Adaptive Wave 9.70% 0.91 2 0.41 0.45 54.16
xxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx xx xxxx xxxx xxxxx
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx xx xxxxx xxxxx xxxxx